Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

Clinical trial NCT02036489 · COMPLETED

Trial details

NCT number: NCT02036489
Sponsor: PETHEMA Foundation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Lymphobkastic Leukemia

Start date: 2008-01-01
Primary completion: 2019-12-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.